Slideshow

Treating Bipolar Depression With Atypical Antipsychotics: Pros, Cons, and Tips

Author(s):

Chris Aiken, MD

Depression predominates across the lifespan in patients with bipolar disorder. Here: A discussion about (and beyond) the four FDA-approved drugs to treat symptoms.

Related Videos
40 years
Have A Nice Day Photo/AdobeStock
Tasphong/AdobeStock
Andrey/AdobeStock
bipolar
bipolar
bipolar
brain research
pills
brain
Related Content
depression
March 19th 2025

Clinical Features Associated With Response to Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression

Justin Allen, MD Lalangi Marasinghe, MD Haley Schuster, MD Mark Mullen, MD Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
Blue Light Blockers: A Behavior Therapy for Mania
October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
bipolar
March 14th 2025

How to Decide Whether Depressions Are Bipolar Depressions

David N. Osser, MD
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
Ronstik/AdobeStock
March 7th 2025

The Week in Review: March 3-7

Megan McSweeney
yana136/AdobeStock
March 5th 2025

Ketamine, TMS Show Promise in Treatment-Resistant Depression in Older Adults

Megan McSweeney
© 2025 MJH Life Sciences

All rights reserved.